QUEST DIAGNOSTICS INC Cash & Equivalents 2006-2026 | DGX
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is QUEST DIAGNOSTICS INC's current cash & equivalents?
QUEST DIAGNOSTICS INC (DGX) annual cash & equivalents for 2025 was $420.0M, a 23.50% decline from 2024. QUEST DIAGNOSTICS INC cash & equivalents for the quarter ending March 31, 2026 was $393.0M.
What was QUEST DIAGNOSTICS INC's cash & equivalents in 2024?
QUEST DIAGNOSTICS INC annual cash & equivalents for 2024 was $549.0M, a 19.97% decline from 2023.
What was QUEST DIAGNOSTICS INC's cash & equivalents in 2023?
QUEST DIAGNOSTICS INC annual cash & equivalents for 2023 was $686.0M, a 117.78% increase from 2022.
What is QUEST DIAGNOSTICS INC's 5-year cash & equivalents CAGR?
QUEST DIAGNOSTICS INC cash & equivalents grew at a compound annual growth rate (CAGR) of 18.36% from FY2020 to FY2025, going from $1.16B to $420.0M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $420.0M | -23.5% | 10-K |
| FY2024 | $549.0M | -20.0% | 10-K |
| FY2023 | $686.0M | +117.8% | 10-K |
| FY2022 | $315.0M | -63.9% | 10-K |
| FY2021 | $872.0M | -24.7% | 10-K |
| FY2020 | $1.16B | -2.9% | 10-K |
| FY2019 | $1.19B | +783.0% | 10-K |
| FY2018 | $135.0M | -1.5% | 10-K |
| FY2017 | $137.0M | -61.8% | 10-K |
| FY2016 | $359.0M | +169.9% | 10-K |
| FY2015 | $133.0M | -30.7% | 10-K |
| FY2014 | $192.0M | +2.7% | 10-K |
| FY2013 | $187.0M | -36.8% | 10-K |
| FY2012 | $296.0M | +79.4% | 10-K |
| FY2011 | $165.0M | -63.3% | 10-K |
| FY2010 | $449.0M | -16.0% | 10-K |
| FY2009 | $534.3M | +110.4% | 10-K |
| FY2008 | $253.9M | +51.5% | 10-K |
| FY2007 | $167.6M | +12.0% | 10-K |
| FY2006 | $149.6M | - | 10-K |